The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

Patients taking Ozempic were about 60% less likely to have an opioid overdose compared to those taking other diabetes drugs.

A study compared the association of semaglutide vs other antidiabetic medications and other GLP-1RAs, including liraglutide ...

The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent ...

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the me ...

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

For the millions of people living with diabetes or obesity, drugs like Ozempic and Wegovy can significantly improve their ...